Optimizing antimicrobial prescribing

International Journal of Antimicrobial Agents

Volumn 36, Issue SUPPL. 3, 2010, Pages

  Isturiz, Raul E ^a  

^a Centro Medico Docente La Trinidad   (Venezuela)

Author keywords

Antibiotic resistance; Antibiotic stewardship; Infection control

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; EXTENDED SPECTRUM BETA LACTAMASE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL VIRULENCE; CLOSTRIDIUM DIFFICILE; DRUG USE; DRUG UTILIZATION; ENTEROCOCCUS; HEALTH CARE COST; HEALTH CARE PRACTICE; HEALTH CARE QUALITY; HUMAN; INFECTION CONTROL; KLEBSIELLA INFECTION; MICROBIOLOGY; MULTIDRUG RESISTANCE; OUTCOME ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PUBLIC HEALTH SERVICE; REVIEW; STAPHYLOCOCCUS;

EID: 78649710745     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(10)70006-6     Document Type: Article

References (43)

1. HW Boucher, GH Talbot, JS Bradley, JE Edwards, D Gilbert, LB Rice Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America Clin Infect Dis 48 2009 1 12
2. M Melzer, SJ Eykyn, WR Gransden, S Chinn Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia Clin Infect Dis 37 2003 1453 1460
3. CA DiazGranados, SM Zimmer, M Klein, JA Jernigan Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis Clin Infect Dis 41 2005 327 333
4. M Tumbarello, T Spanu, M Sanguinetti, R Citton, E Montuori, F Leone Bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome Antimicrob Agents Chemother 50 2006 498 504
5. KT Kwon, WS Oh, JH Song, HH Chang, SI Jung, SW Kim Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia J Antimicrob Chemother 59 2007 525 530
6. V Aloush, S Navon-Venezia, Y Seigman-Igra, S Cabili, Y Carmeli Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact Antimicrob Agents Chemother 50 2006 43 48
7. D Marchaim, S Navon-Venezia, MJ Schwaber, Y Carmeli Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes Antimicrob Agents Chemother 52 2008 1413 1418
8. MH Kollef, G Sherman, S Ward, VJ Fraser Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients Chest 115 1999 462 474
9. TH Dellit, RC Owens, JE McGowan Jr, DN Gerding, RA Weinstein, JP Burke Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship Clin Infect Dis 44 2007 159 177
10. KL Lawrence, MH Kollef Antimicrobial stewardship in the intensive care unit: advances and obstacles Am J Respir Crit Care Med 179 2009 434 438
11. FJ Cooke, AH Holmes The missing care bundle: antibiotic prescribing in hospitals Int J Antimicrob Agents 30 2007 25 29
12. DL Paterson The role of antimicrobial management programs in optimizing antibiotic prescribing within hospitals Clin Infect Dis 42 Suppl. 2 2006 S90 S95
13. M Paul, I Silbiger, S Grozinsky, K Soares-Weiser, L Leibovici Beta-lactam antibiotic monotherapy versus beta-lactam-aminoglycoside antibiotic combination therapy for sepsis Cochrane Database Syst Rev 1 2006 CD003344.
14. M Paul, I Benuri-Silbiger, K Soares-Weiser, L Leibovici Beta-lactam monotherapy versus beta-lactam-aminoglycoside combination therapy for sepsis in immuno-competent patients: systematic review and meta-analysis of randomised trials BMJ 328 2004 668 Erratum in: BMJ 2004;328:884.
15. ME Falagas, DK Matthaiou, IA Bliziotis The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials J Antimicrob Chemother 57 2006 639 647
16. SE Cosgrove, GA Vigliani, VG Fowler Jr, E Abrutyn, GR Corey, DP Levine Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic Clin Infect Dis 48 2009 713 721
17. D Raveh, B Rudensky, Y Schlesinger, S Benenson, AM Yinnon Susceptibility trends in bacteraemias: analyses of 7544 patient-unique bacteraemic episodes spanning 11 years (1990-2000) J Hosp Infect 55 2003 196 203
18. IA Bliziotis Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials Clin Infect Dis 41 2005 149 158
19. M Hegreness, N Shoresh, D Damian, D Hartl, R Kishony Accelerated evolution of resistance in multidrug environments Proc Natl Acad SciUSA 105 2008 13977 13981
20. R Ben-Ami, J Rodríguez-Baño, H Arslan, JD Pitout, C Quentin, ES Calbo A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae in nonhospitalized patients Clin Infect Dis 49 2009 682 690
21. V Schechner, V Nobre, KS Kaye, M Leshno, M Giladi, P Rohner Gram-negative bacteremia upon hospital admission: when should Pseudomonas aeruginosa be suspected? Clin Infect Dis 48 2009 580 586
22. A Robicsek, M Suseno, JL Beaumont, RB Thomson Jr, LR Peterson Prediction of methicillin-resistant Staphylococcus aureus involvement in disease sites by concomitant nasal sampling J Clin Microbiol 46 2008 588 592
23. C Pulcini, S Defres, I Aggarwal, D Nathwani, P Davey Design of a 'day 3 bundle' to improve the reassessment of inpatient empirical antibiotic prescriptions J Antimicrob Chemother 61 2008 1384 1388
24. FR Cockerill 3rd, GS Reed, JG Hughes, CA Torgerson, EA Vetter, WS Harmsen Clinical comparison of BACTEC 9240 Plus Aerobic/F resin bottles and the isolator aerobic culture system for detection of bloodstream infections J Clin Microbiol 35 1997 1469 1472
25. G Durmaz, T Us, A Aydinli, A Kiremitci, N Kiraz, Y Akgün Optimum detection times for bacteria and yeast species with the BACTEC 9120 aerobic blood culture system: evaluation for a 5-year period in a Turkish university hospital J Clin Microbiol 41 2003 819 821
26. MJ Rybak Pharmacodynamics: relation to antimicrobial resistance Am J Med 119 6 Suppl. 1 2006 S37 S44 discussion S62-70.
27. JA Roberts, J Lipman Pharmacokinetic issues for antibiotics in the critically ill patient Crit Care Med 37 2009 840 851
28. J Chastre, M Wolff, JY Fagon, S Chevret, F Thomas, D Wermert PneumA Trial Group Comparison of 8 vs 15 days of antibiotic therapy for ventilator- associated pneumonia in adults: a randomized trial JAMA 290 2003 2588 2598
29. JD Siegel, E Rhinehart, M Jackson, L Chiarello, the Healthcare Infection Control Practices Advisory Committee Management of multidrug-resistant organisms in healthcare settings, 2006 2006 Centers for Disease Control and Prevention (CDC) http://www.cdc.gov/ncidod/dhqp/pdf/ar/mdroGuideline2006.pdf [accessed 14 October 2010].
30. KL Buising, KA Thursky, MB Robertson, JF Black, AC Street, MJ Richards Electronic antibiotic stewardship: reduced consumption of broad-spectrum antibiotics using a computerized antimicrobial approval system in a hospital setting J Antimicrob Chemother 62 2008 608 616
31. KL Buising, KA Thursky, JF Black, L MacGregor, AC Street, MP Kennedy Improving antibiotic prescribing for adults with community-acquired pneumonia: Does a computerised decision support system achieve more than academic detailing alone? A time-series analysis BMC Med Inform Decis Mak 8 2008 35
32. P Eggimann, D Pittet Infection control in the ICU Chest 120 2001 2059 2093
33. AL Pakyz, C MacDougall, M Oinonen, RE Polk Trends in antibacterial use in US academic health centers: 2002 to 2006 Arch Int Med 168 2008 2254 2260
34. SD Pope, TH Dellit, RC Owens, TM Hooton, Infectious Diseases Society of America, Society for Healthcare Epidemiology of America Results of survey on implementation of Infectious Diseases Society of America and Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship Infect Control Hosp Epidemiol 30 2009 97 98
35. J Bruce, FM MacKenzie, B Cookson, J Mollison, JW van der Meer, V Krcmery ARPAC Steering Group Antibiotic stewardship and consumption: findings from a pan-European hospital study J Antimicrob Chemother 64 2009 853 860
36. DH Solomon, L Van Houten, RJ Glynn, L Baden, K Curtis, H Schrager Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center Arch Intern Med 161 2001 1897 1902 (Pubitemid 32762737)
37. GL Fraser, P Stogsdill, JD Dickens Jr, DE Wennberg, RP Smith Jr, BS Prato Antibiotic optimization. An evaluation of patient safety and economic outcomes Arch Int Med 157 1997 1689 1694
38. EM Brown, D Nathwani Antibiotic cycling or rotation: a systematic review of the evidence of efficacy J Antimicrob Chemother 55 2005 6 9
39. SK Fridkin Routine cycling of antimicrobial agents as an infection-control measure Clin Infect Dis 36 2003 1438 1444
40. CT Bergstrom, M Lo, M Lipsitch Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals Proc Natl Acad Sci USA 101 2004 13285 13290
41. S Bonhoeffer, M Lipsitch, BR Levin Evaluating treatment protocols to prevent antibiotic resistance Proc Natl Acad SciUSA 94 1997 12106 12111
42. MJ Bonten, DJ Austin, M Lipsitch Understanding the spread of antibiotic-resistant pathogens in hospitals: mathematical models as tools for control Clin Infect Dis 33 2001 1739 1746
43. A Sandiumenge, E Diaz, A Rodriguez, L Vidaur, L Canadell, M Olona Impact of diversity of antibiotic use on the development of antimicrobial resistance J Antimicrob Chemother 57 2006 1197 1204